AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10148919 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithotripsy plus ursodiol (Actigall, Ciba Geigy)
Number of subjects: 100
Study 10148919 — intervention group
Group type: COMPARATOR
Intervention: Lithotripsy alone
Number of subjects: 100
Study 6893580 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg sublingual molsidomine
Number of subjects: 9
Study 6893580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 30797692 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at true acupoints
Number of subjects: 62
Study 30797692 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 62
Study 28228368 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based, Spanish-language, individually tailored physical activity intervention
Number of subjects: 205
Study 28228368 — intervention group
Group type: COMPARATOR
Intervention: Wellness contact control
Number of subjects: 205
Study 25751447 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage intervention
Number of subjects: 117
Study 25751447 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 117
Study 24383496 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic-impregnated VPS
Number of subjects: 1200
Study 24383496 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver-impregnated VPS
Number of subjects: 1200
Study 24383496 — intervention group
Group type: COMPARATOR
Intervention: Standard silicone VPS (comparator)
Number of subjects: 1200
Study 21967645 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor 270 mg (3×90 mg tablets) after a 10-h overnight fast
Number of subjects: 26
Study 21967645 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor 270 mg (3×90 mg tablets) after a standard high-fat, high-calorie breakfast
Number of subjects: 26
Study 21967645 — intervention group
Group type: COMPARATOR
Intervention: Ticagrelor after a standard high-fat, high-calorie breakfast
Number of subjects: 26
Study 21967645 — intervention group
Group type: COMPARATOR
Intervention: AR-C124910XX after a standard high-fat, high-calorie breakfast
Number of subjects: 26
Study 19296870 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (50 microg or 2000 IU daily for 12 weeks)
Number of subjects: 162
Study 19296870 — intervention group
Group type: COMPARATOR
Intervention: Placebo (matching placebo for 12 weeks)
Number of subjects: 162
Study 17469042 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone (30 mg per day)
Number of subjects: 30
Study 17469042 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 15094148 — intervention group
Group type: COMPARATOR
Intervention: Tai Chi gait (TCG)
Number of subjects: 10
Study 11989392 — intervention group
Group type: EXPERIMENTAL
Intervention: Exogenous hyaluronan administration
Number of subjects: 0
Study 11989392 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronan-based biomaterials
Number of subjects: 0
Study 9764566 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiographers
Number of subjects: 0
Study 9764566 — intervention group
Group type: COMPARATOR
Intervention: Nonradiographers
Number of subjects: 0
Study 1399475 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous long line silastic catheters
Number of subjects: 0
Study 1399475 — intervention group
Group type: COMPARATOR
Intervention: Conventional intravenous cannulas
Number of subjects: 0
Study 3540879 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 200 mg
Number of subjects: 224
Study 3540879 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprofen 400 mg
Number of subjects: 224
Study 3540879 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 650 mg
Number of subjects: 224
Study 3540879 — intervention group
Group type: COMPARATOR
Intervention: Codeine 60 mg
Number of subjects: 224
Study 3540879 — intervention group
Group type: COMPARATOR
Intervention: Propoxyphene HCl 65 mg
Number of subjects: 224
Study 3540879 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 3540879 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 650 mg with codeine 60 mg
Number of subjects: 224
Study 31442848 — intervention group
Group type: EXPERIMENTAL
Intervention: Serious game
Number of subjects: 27
Study 31442848 — intervention group
Group type: COMPARATOR
Intervention: Control (text-based material)
Number of subjects: 27
Study 30326872 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual placement and support
Number of subjects: 96
Study 30326872 — intervention group
Group type: COMPARATOR
Intervention: Traditional vocational rehabilitation
Number of subjects: 96
Study 26438656 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS values maintained at <50 (Group 1)
Number of subjects: 60
Study 26438656 — intervention group
Group type: COMPARATOR
Intervention: BIS values maintained at ≥50 with 4-7% desflurane in a 50% O2-air mixture (Group 2)
Number of subjects: 60
Study 24641522 — intervention group
Group type: EXPERIMENTAL
Intervention: Clobetasol propionate (CP) 0.05% ointment
Number of subjects: 54
Study 24641522 — intervention group
Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MMF) 0.1% ointment
Number of subjects: 54
Study 22581482 — intervention group
Group type: EXPERIMENTAL
Intervention: Worry exposure therapy (n = 29)
Number of subjects: 56
Study 22581482 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied relaxation therapy (n = 27)
Number of subjects: 56
Study 22581482 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants (control group, n = 33)
Number of subjects: 56
Study 22581482 — intervention group
Group type: EXPERIMENTAL
Intervention: Post therapy (immediate outcome)
Number of subjects: 56
Study 22581482 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term follow-up (6- and 12-month)
Number of subjects: 56
Study 19504425 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 80
Study 19504425 — intervention group
Group type: COMPARATOR
Intervention: Nystatin
Number of subjects: 80
Study 17653011 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulinastatin (1000000 U total dose)
Number of subjects: 30
Study 17653011 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 16671340 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilnidipine
Number of subjects: 110
Study 16671340 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 110
Study 11991872 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual aspiration
Number of subjects: 60
Study 11991872 — intervention group
Group type: COMPARATOR
Intervention: Chest tube drainage
Number of subjects: 60
Study 9471043 — intervention group
Group type: EXPERIMENTAL
Intervention: Holmium laser enucleation of the prostate (HoLEP) combined with mechanical morcellation
Number of subjects: 14
Study 7551644 — intervention group
Group type: EXPERIMENTAL
Intervention: Causal models of factors affecting coronary heart disease risk
Number of subjects: 0
Study 7551644 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive actions rated by individuals
Number of subjects: 0
Study 2154314 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachytherapy alone or with external beam radiation therapy or surgery
Number of subjects: 0
Study 2154314 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative radiation therapy
Number of subjects: 0
Study 2154314 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermia with radiation therapy
Number of subjects: 0
Study 2154314 — intervention group
Group type: EXPERIMENTAL
Intervention: Particle irradiation (protons, neutrons, stripped nuclei, and pions)
Number of subjects: 0
Study 2154314 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusional (intravenous) chemotherapy with radiation therapy
Number of subjects: 0
Study 2154314 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarterial monoclonal antibodies with radionuclides and intraarterial chemotherapy with radiation therapy
Number of subjects: 0
Study 7357805 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% ophthalmic solution (2 drops to each eye with precautions)
Number of subjects: 0
Study 7357805 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol 0.5% ophthalmic solution (1 drop to each eye with no special precautions)
Number of subjects: 0
Study 7357805 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5% ophthalmic solution
Number of subjects: 0
Study 30778518 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physical activity intervention
Number of subjects: 1022
Study 30778518 — intervention group
Group type: COMPARATOR
Intervention: Health education control
Number of subjects: 1022
Study 28665470 — intervention group
Group type: EXPERIMENTAL
Intervention: Local Brain Radiotherapy (LBRT)
Number of subjects: 54
Study 28665470 — intervention group
Group type: COMPARATOR
Intervention: Whole Brain Radiotherapy (WBRT)
Number of subjects: 54
Study 26436683 — intervention group
Group type: EXPERIMENTAL
Intervention: Day Camp Intervention Arm (DCIA)
Number of subjects: 115
Study 26436683 — intervention group
Group type: COMPARATOR
Intervention: Standard Intervention Arm (SIA)
Number of subjects: 115
Study 22729611 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy plus multitargeted antiangiogenic TKI
Number of subjects: 3337
Study 20732768 — intervention group
Group type: EXPERIMENTAL
Intervention: EGFR overexpression (high levels)
Number of subjects: 533
Study 20732768 — intervention group
Group type: EXPERIMENTAL
Intervention: EGFR combined with clinical parameters
Number of subjects: 533
Study 19241490 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 227
Study 19241490 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher family support
Number of subjects: 227
Study 19241490 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor physical health, depressive symptoms, and lower emotional HRQL
Number of subjects: 227
Study 16754825 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based asthma education intervention
Number of subjects: 221
Study 16754825 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 221
Study 14679127 — intervention group
Group type: EXPERIMENTAL
Intervention: Topotecan (1.5 mg/m(2)/day for 5 days)
Number of subjects: 226
Study 14679127 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m(2)/day as a 3‐h infusion every 21 days)
Number of subjects: 226
Study 11689808 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (3 microg. kg. min(‐1))
Number of subjects: 48
Study 11689808 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitroglycerin (bolus injection of 2 mg)
Number of subjects: 48
Study 11689808 — intervention group
Group type: COMPARATOR
Intervention: Control (preischemic values)
Number of subjects: 48
Study 9039301 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol cream (50 micrograms/g)
Number of subjects: 421
Study 9039301 — intervention group
Group type: COMPARATOR
Intervention: Betamethasone 17-valerate cream (1 mg/g)
Number of subjects: 421
Study 8133350 — intervention group
Group type: EXPERIMENTAL
Intervention: Let Me Decide directive
Number of subjects: 128
Study 8133350 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Directive
Number of subjects: 128
Study 8133350 — intervention group
Group type: EXPERIMENTAL
Intervention: No preference
Number of subjects: 128
Study 2774051 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone standing position
Number of subjects: 10
Study 2774051 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 10
Study 2774051 — intervention group
Group type: COMPARATOR
Intervention: Sitting and prone standing positions
Number of subjects: 10
Study 127815 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 0
Study 127815 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 0
Study 31444008 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 0.5%
Number of subjects: 85
Study 31444008 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 1%
Number of subjects: 85
Study 31444008 — intervention group
Group type: COMPARATOR
Intervention: Saline tears (placebo)
Number of subjects: 85
Study 24927783 — intervention group
Group type: EXPERIMENTAL
Intervention: Qigong intervention plus usual care and rehabilitation (N = 29)
Number of subjects: 58
Study 24927783 — intervention group
Group type: COMPARATOR
Intervention: Usual care and rehabilitation alone (N = 29)
Number of subjects: 58
Study 23416451 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral and fMRI evidence supporting event representations coalescing around clusters of mutually predicting stimuli.
Number of subjects: 0
Study 23416451 — intervention group
Group type: EXPERIMENTAL
Intervention: fMRI adaptation and multivoxel pattern analysis techniques used to analyze event representations.
Number of subjects: 0
Study 21995829 — intervention group
Group type: EXPERIMENTAL
Intervention: Offering survey results as an incentive
Number of subjects: 4796
Study 21995829 — intervention group
Group type: COMPARATOR
Intervention: Control group (no offer of results)
Number of subjects: 4796
Study 19950738 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal acute normovolemic hemodilution (ANH)
Number of subjects: 101
Study 19950738 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 101
Study 18028979 — intervention group
Group type: EXPERIMENTAL
Intervention: Object axes allowing for the highest orientation discrimination (horizontal/vertical)
Number of subjects: 0
Study 18028979 — intervention group
Group type: EXPERIMENTAL
Intervention: Method of adjustment
Number of subjects: 0
Study 15037415 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 3 mg of drospirenone + 30 microg of ethinyl estradiol (DRSP + EE)
Number of subjects: 22
Study 15037415 — intervention group
Group type: COMPARATOR
Intervention: Control group studied during the first menstrual cycle at the follicular phase and at the luteal phase, and during the third cycle at the luteal phase
Number of subjects: 22
Study 11722416 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum transferrin receptor (sTfR) and TfR-Index
Number of subjects: 561
Study 11722416 — intervention group
Group type: EXPERIMENTAL
Intervention: LogTfR:Fer ratio
Number of subjects: 561
Study 11722416 — intervention group
Group type: EXPERIMENTAL
Intervention: LogTfR:Fer ratio after resolution of inflammation
Number of subjects: 561
Study 9230571 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolving Consumer Households
Number of subjects: 112
Study 9230571 — intervention group
Group type: COMPARATOR
Intervention: Independent Living apartments
Number of subjects: 112
Study 7735152 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral acoustic stimulation
Number of subjects: 12
Study 7735152 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-subject test results (n = 18)
Number of subjects: 12
Study 7735152 — intervention group
Group type: EXPERIMENTAL
Intervention: TEOAE suppression measurements
Number of subjects: 12
Study 3320785 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive treatment
Number of subjects: 0
Study 3320785 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 29073802 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusal appliance (OA)
Number of subjects: 116
Study 29073802 — intervention group
Group type: COMPARATOR
Intervention: Relaxation training (RT) combined with information (Control group)
Number of subjects: 116
Study 29073802 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential treatment (ST)
Number of subjects: 116
Study 29073802 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall comparison of OA vs RT/Co
Number of subjects: 116
Study 29073802 — intervention group
Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 116
Study 28315780 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in grams plus high/medium/low text
Number of subjects: 2509
Study 28315780 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in grams and %DV
Number of subjects: 2509
Study 28315780 — intervention group
Group type: COMPARATOR
Intervention: Current NFL without AS
Number of subjects: 2509
Study 28315780 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in grams only
Number of subjects: 2509
Study 28315780 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed NFL with AS in teaspoons
Number of subjects: 2509
Study 28315780 — intervention group
Group type: EXPERIMENTAL
Intervention: %DV for determining healthier products
Number of subjects: 2509
Study 28315780 — intervention group
Group type: EXPERIMENTAL
Intervention: Grams alone for determining healthier products
Number of subjects: 2509
Study 28315780 — intervention group
Group type: COMPARATOR
Intervention: No label
Number of subjects: 2509
Study 25745357 — intervention group
Group type: EXPERIMENTAL
Intervention: CI increased group
Number of subjects: 29
Study 25745357 — intervention group
Group type: COMPARATOR
Intervention: CI constant group
Number of subjects: 29
Study 25745357 — intervention group
Group type: EXPERIMENTAL
Intervention: CI percent change
Number of subjects: 29
Study 23169400 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating of constituents' needs or opinions as a factor influencing health policy priorities
Number of subjects: 75
Study 23169400 — intervention group
Group type: EXPERIMENTAL
Intervention: Rating of evidence of scientific effectiveness as a factor influencing health policy priorities
Number of subjects: 75
Study 22276506 — intervention group
Group type: EXPERIMENTAL
Intervention: QRHX decoction (composed of Huangbai, Chishao, Bixie, Danshen, Ezhu, Qingfengteng, raw Huangqi, Jinyinhua, Tufuling, Wugong, Fengfang, raw Yiyiren, cooked with water as 400 ml liquid)
Number of subjects: 86
Study 22276506 — intervention group
Group type: COMPARATOR
Intervention: QRHX decoction plus methotrexate (MTX)
Number of subjects: 86
Study 19590482 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture (8 sessions over 4 weeks)
Number of subjects: 77
Study 19590482 — intervention group
Group type: COMPARATOR
Intervention: Steroid treatment (prednisolone 20 mg daily for 2 weeks followed by 10 mg daily for 2 weeks)
Number of subjects: 77
Study 16876164 — intervention group
Group type: EXPERIMENTAL
Intervention: Basigin expression in ovarian endometriotic tissue
Number of subjects: 0
Study 16876164 — intervention group
Group type: EXPERIMENTAL
Intervention: Basigin expression in eutopic endometrium
Number of subjects: 0
Study 16876164 — intervention group
Group type: EXPERIMENTAL
Intervention: Basigin expression in endometriotic lesions
Number of subjects: 0
Study 12632273 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with biweekly FOLFOX regimen (FOL: 500 mg/m2, F: 2000 mg/m2 for 2 days, OX: 85 mg/m2)
Number of subjects: 42
Study 11108443 — intervention group
Group type: EXPERIMENTAL
Intervention: Local nasal immunotherapy (LNIT) with powder extract of Graminaceae or Parietaria pollens
Number of subjects: 43
Study 11108443 — intervention group
Group type: COMPARATOR
Intervention: Symptomatic pharmacological treatment only (Control)
Number of subjects: 43
Study 8601647 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine 250 mg daily (21 patients)
Number of subjects: 63
Study 8601647 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbinafine 500 mg daily for 1 week every month (21 patients)
Number of subjects: 63
Study 8601647 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole 400 mg daily for 1 week every month (21 patients)
Number of subjects: 63
Study 1458859 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer program (group A)
Number of subjects: 39
Study 1458859 — intervention group
Group type: COMPARATOR
Intervention: Control group (group B)
Number of subjects: 39
Study 6463598 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazide (50 mg hydrochlorthiazide)
Number of subjects: 48
Study 6463598 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 30802196 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sufentanil (1 μg/kg) and midazolam (0.2 mg/kg) (Group SM)
Number of subjects: 44
Study 30802196 — intervention group
Group type: COMPARATOR
Intervention: Inhalational sevoflurane (2.0 MAC) (Group S)
Number of subjects: 44
Study 28619016 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic mask oxygen-providing (3 L/min during intubation)
Number of subjects: 54
Study 28619016 — intervention group
Group type: COMPARATOR
Intervention: Nasal catheter oxygen-providing
Number of subjects: 54
Study 26974018 — intervention group
Group type: EXPERIMENTAL
Intervention: Rocuronium 1 mg/kg reversed with Sugammadex 2-4 mg/kg
Number of subjects: 240
Study 26974018 — intervention group
Group type: COMPARATOR
Intervention: Suxamethonium 1 mg/kg for induction, Rocuronium 0.3 mg/kg for maintenance, Neostigmine 0.03 mg/kg for reversal
Number of subjects: 240
Study 23253641 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive behavioural therapy (cCBT)
Number of subjects: 34
Study 23253641 — intervention group
Group type: COMPARATOR
Intervention: Computer-administered attention placebo program with psychoeducational content (CPE)
Number of subjects: 34
Study 23253641 — intervention group
Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 34
Study 23253641 — intervention group
Group type: COMPARATOR
Intervention: CPE
Number of subjects: 34
Study 22768645 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated vehicles in quiet settings
Number of subjects: 0
Study 22768645 — intervention group
Group type: COMPARATOR
Intervention: Simulated vehicles with moderate background traffic sound
Number of subjects: 0
Study 22768645 — intervention group
Group type: EXPERIMENTAL
Intervention: Signal-to-noise ratio for straight-or-turn judgment
Number of subjects: 0
Study 19222417 — intervention group
Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg
Number of subjects: 3151
Study 19222417 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole 40 mg
Number of subjects: 3151
Study 19222417 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Helicobacter pylori status
Number of subjects: 3151
Study 19222417 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 3151
Study 19222417 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 3151
Study 19222417 — intervention group
Group type: EXPERIMENTAL
Intervention: No acid regurgitation or epigastric pain pre-treatment
Number of subjects: 3151